Considerations for future trials in cerebral cavernous malformations

Marco Cenzato; Ulrich Sure; Giuseppe Lanzino; Davide Boeris; Torstein Meling; Luca Regli; Andreas Gruber; Peter Vajkoczy; Michael Lawton

doi:10.1016/S1474-4422(24)00321-1

Considerations for future trials in cerebral cavernous malformations

Marco Cenzato^*, Ulrich Sure, Giuseppe Lanzino, Davide Boeris, Torstein Meling, Luca Regli, Andreas Gruber, Peter Vajkoczy, Michael Lawton

^*Corresponding author af dette arbejde

Afdeling for Hjerne- og Nervekirurgi

Originalsprog	Engelsk
Tidsskrift	The Lancet Neurology
Vol/bind	23
Udgave nummer	10
Sider (fra-til)	965
ISSN	1474-4422
DOI	https://doi.org/10.1016/S1474-4422(24)00321-1
Status	Udgivet - okt. 2024

Adgang til dokumentet

10.1016/S1474-4422(24)00321-1

Andre filer og links

Link to publication in Scopus

Citationsformater

@article{2fa63085314446a5850bb807801a756e,

title = "Considerations for future trials in cerebral cavernous malformations",

keywords = "Humans, Hemangioma, Cavernous, Central Nervous System, Clinical Trials as Topic/methods",

author = "Marco Cenzato and Ulrich Sure and Giuseppe Lanzino and Davide Boeris and Torstein Meling and Luca Regli and Andreas Gruber and Peter Vajkoczy and Michael Lawton",

year = "2024",

month = oct,

doi = "10.1016/S1474-4422(24)00321-1",

language = "English",

volume = "23",

pages = "965",

journal = "The Lancet Neurology",

issn = "1474-4422",

publisher = "Elsevier Limited",

number = "10",

}

TY - JOUR

T1 - Considerations for future trials in cerebral cavernous malformations

AU - Cenzato, Marco

AU - Sure, Ulrich

AU - Lanzino, Giuseppe

AU - Boeris, Davide

AU - Meling, Torstein

AU - Regli, Luca

AU - Gruber, Andreas

AU - Vajkoczy, Peter

AU - Lawton, Michael

PY - 2024/10

Y1 - 2024/10

KW - Humans

KW - Hemangioma, Cavernous, Central Nervous System

KW - Clinical Trials as Topic/methods

UR - http://www.scopus.com/inward/record.url?scp=85203974560&partnerID=8YFLogxK

U2 - 10.1016/S1474-4422(24)00321-1

DO - 10.1016/S1474-4422(24)00321-1

M3 - Letter

C2 - 39304258

SN - 1474-4422

VL - 23

SP - 965

JO - The Lancet Neurology

JF - The Lancet Neurology

IS - 10

ER -